Ticker

April 16, 2026 Combining always-on spectral imaging with AI reconstruction to deliver enhanced levels of image quality, efficiency, and clinical insight across radiology, cardiology, and oncology Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced it has received U.S. Food and Drug Administration 510(k) clearance for the Philips Spectral CT Verida…

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

JPMorgan Chase and Co. increased its holdings in shares of Koninklijke Philips N.V. (NYSE: PHG) by 28.2% during the undefined quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 112,322 shares of the technology company's stock after acquiring an additional 24,706 shares during

April 2, 2026 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that Carla Goulart Peron, MD, Chief Medical Officer at Philips, has been appointed to the Board of Directors of the Medical Device Innovation Consortium (MDIC). Founded in 2012, MDIC is a unique public-private partnership that brings stakeholders across the medical device spectrum…

PHG secures FDA nod for AI-powered EchoNavigator R5.0, boosts its push into minimally invasive heart repair and expands U.S. market reach.